SERPERA has obtained the medical device license from the Taiwan Food and Drug Administration(TFDA).
Sep 20, 2019
1 min read
USH Inc. product, the SERPERA Blood Cell Separator, received the TFDA medical device license on September 20, 2019. Sales of the product will commence in October.